{
    "Trade/Device Name(s)": [
        "Athelas One"
    ],
    "Submitter Information": "Athelas Inc.",
    "510(k) Number": "K181288",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071967"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GKZ"
    ],
    "Summary Letter Date": "May 9, 2018",
    "Summary Letter Received Date": "May 16, 2018",
    "Submission Date": "September 15, 2018",
    "Regulation Number(s)": [
        "21 CFR 864.5520"
    ],
    "Regulation Name(s)": [
        "Automated differential cell counter"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "White blood cells (WBC)",
        "Neutrophil percentage (NEUT%)"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "K2EDTA venous whole blood"
    ],
    "Specimen Container(s)": [
        "K2EDTA tube",
        "Athelas One test strip"
    ],
    "Instrument(s)/Platform(s)": [
        "Athelas One analyzer",
        "Companion tablet/mobile application"
    ],
    "Method(s)/Technology(ies)": [
        "Microfluidic test strip",
        "Image analysis",
        "Computer vision"
    ],
    "Methodologies": [
        "Cell monolayer imaging",
        "Automated differential cell counting"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Athelas One automated differential cell counter for WBC and neutrophil % in capillary and K2EDTA venous whole blood using microfluidic imaging and computer vision",
    "Indications for Use Summary": "Quantitative determination of white blood cells (WBC) and neutrophil percentages (NEUT%) in capillary or K2EDTA venous whole blood for adult patients (aged 21 and older) in clinical laboratory and point of care settings, for in vitro diagnostic use only",
    "fda_folder": "Hematology"
}